Dornase alfa, a recombinant desoxyribonuclease, has been approved by the US Food and Drug Administration (FDA) for the treatment of cystic fibrosis, suggesting that administration with DNase I is tolerable and safe for patients. This evidence concerns the gene DNASE1 and cystic fibrosis.